OCUL
Ocular Therapeutix Inc
Halal Rating :
Last Price
$8.00
Last updated:
Market Cap
-
7D Change
-1.48%
1 Year Change
96.56%
Company Overview
Industries
Exchange
Next Earnings Date
Ocular Therapeutix Inc is a biopharmaceutical company focused on developing and commercializing therapies for diseases and conditions of the eye. The company's main product is DEXTENZA®, an FDA-approved corticosteroid intracanalicular insert for the treatment of ocular inflammation and pain following ophthalmic surgery. They also have several product candidates in their pipeline targeting various ophthalmic conditions.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $15.43m | $64.65m | - | $3.22m | 0.00% | 4.99% |
| June 30, 2024 | $16.44m | $63.23m | - | $3.2m | 0.00% | 5.05% |
| March 31, 2024 | $14.77m | $78.39m | - | $32.0m | 0.00% | 40.82% |
Company Impact
Help us evaluate Ocular Therapeutix Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.